Bionano Genomics, Inc. Net Income Loss

• Bionano Genomics, Inc. showed an increase of +76.4% in Net Income Loss from 2024 to 2025.
• This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Bionano Genomics, Inc.'s Net Income Loss has declined by 13.0%.
• Historical annual values: Fiscal year 2025: -$26.40 million | Fiscal year 2024: -$112.02 million | Fiscal year 2023: -$232.49 million | Fiscal year 2022: -$132.60 million | Fiscal year 2021: -$72.44 million | Fiscal year 2020: -$41.11 million | Fiscal year 2019: -$29.82 million | Fiscal year 2018: -$18.50 million | Fiscal year 2017: -$23.37 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026